A detailed history of Geo Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Geo Wealth Management, LLC holds 13,865 shares of BMY stock, worth $774,082. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,865
Previous 11,397 21.65%
Holding current value
$774,082
Previous $473,000 51.59%
% of portfolio
0.03%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $97,880 - $127,719
2,468 Added 21.65%
13,865 $717,000
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $278,731 - $366,955
-6,925 Reduced 37.8%
11,397 $473,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $879,089 - $996,716
-18,322 Closed
0 $0
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $375,491 - $425,734
7,826 Added 74.56%
18,322 $993,000
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $412,322 - $492,014
8,505 Added 427.17%
10,496 $538,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $22,519 - $25,179
389 Added 24.28%
1,991 $115,000
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $2,612 - $2,900
41 Added 2.63%
1,602 $102,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $2,299 - $2,608
-35 Reduced 2.19%
1,561 $108,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $4,725 - $5,595
-69 Reduced 4.14%
1,596 $114,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $216 - $127,938
1,665 New
1,665 $118,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $65,146 - $76,310
-1,101 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$61.91 - $67.42 $68,162 - $74,229
1,101 New
1,101 $74,000
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $251,413 - $327,946
-5,109 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $218,511 - $259,077
5,109 New
5,109 $259,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Geo Wealth Management, LLC Portfolio

Follow Geo Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geo Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geo Wealth Management, LLC with notifications on news.